ShareValue scores for 300791.SHE: Valuation 52, Quality 50, Growth 49, Health 37.
300791.SHESZSE
Sirio Pharma
CN¥16.95
(+0.24%)
300791.SHESZSE
Sirio Pharma
CN¥16.95(+0.24%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Stressed
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
3% to 16%
Rating
Trap Risk
Return
3% to 16%
Valuation
52
Fair Value
Price vs Value
Quality
50
Moderate
Business Strength
Growth
49
Moderate
Revenue & Earnings
Health
37
Stressed
Financial Stability
Momentum
32
Bearish
Price Trend
Company Details
About
Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China.
Market Cap$5.23B
P/E Ratio43.1
Dividend Yield0.78%
Sector Rank#1037
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026